• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Public Health . SARS-CoV-2 Infection During the First and Second Pandemic Waves in Spain: the ENE-COVID Study

tetano

Editor, Senior Moderator
Am J Public Health


. 2023 Mar 9;e1-e12.
doi: 10.2105/AJPH.2023.307233. Online ahead of print.
SARS-CoV-2 Infection During the First and Second Pandemic Waves in Spain: the ENE-COVID Study


Beatriz Pérez-Gómez[SUP] 1 [/SUP], Roberto Pastor-Barriuso[SUP] 1 [/SUP], Nerea Fernández-de-Larrea[SUP] 1 [/SUP], Miguel A Hernán[SUP] 1 [/SUP], Mayte Pérez-Olmeda[SUP] 1 [/SUP], Jesús Oteo-Iglesias[SUP] 1 [/SUP], Pablo Fernández-Navarro[SUP] 1 [/SUP], Aurora Fernández-García[SUP] 1 [/SUP], Mariano Martín[SUP] 1 [/SUP], Israel Cruz[SUP] 1 [/SUP], José L Sanmartín[SUP] 1 [/SUP], José León-Paniagua[SUP] 1 [/SUP], Juan F Muñoz-Montalvo[SUP] 1 [/SUP], Faustino Blanco[SUP] 1 [/SUP], Raquel Yotti[SUP] 1 [/SUP], Marina Pollán[SUP] 1 [/SUP]



Affiliations

Abstract

Objectives. To describe participant characteristics associated with severe acute respiratory syndrome coronavirus 2 infection in Spain's first 2 COVID-19 waves per the Spanish National Seroepidemiological Survey of SARS-CoV-2 Infection (ENE-COVID). Methods. A representative cohort of the noninstitutionalized Spanish population, selected through stratified 2-stage sampling, answered a questionnaire and received point-of-care testing April to June 2020 (first wave: n = 68 287); previously seronegative participants repeated the questionnaire and test November 2020 (second wave: n = 44 451). We estimated seropositivity by wave and participant characteristics, accounting for sampling weights, nonresponse, and design effects. Results. We found that 6.0% (95% confidence interval [CI] = 5.7%, 6.4%) of Spain's population was infected by June and 3.8% (95% CI = 3.5%, 4.1%) more by November 2020. Both genders were equally affected. Seroprevalence decreased with age in adults 20 years and older in the second wave; socioeconomic differences increased. Health care workers were affected at 11.1% (95% CI = 9.0%, 13.6%) and 6.1% (95% CI = 4.4%, 8.5%) in the first and second waves, respectively. Living with an infected person increased infection risk to 22.1% (95% CI = 18.9%, 25.6%) in the first and 35.0% (95% CI = 30.8%, 39.4%) in the second wave. Conclusions. ENE-COVID characterized the first 2 pandemic waves, when information from surveillance systems was incomplete. (Am J Public Health. Published online ahead of print March 9, 2023:e1-e12. https://doi.org/10.2105/AJPH.2023.307233).
 
Back
Top Bottom